Medicine and Dentistry
Medical Cannabis
88%
Cannabis
78%
Adverse Event
55%
Quality of Life
41%
Psilocybine
37%
Sleep Quality
30%
Mental Health
25%
Generalized Anxiety Disorder
22%
Psychotomimetic
22%
Patient-Reported Outcome
15%
Combination Therapy
13%
Chronic Pain
13%
Epileptic Seizure
12%
Depressive Disorder
12%
Treatment Resistant Depression
11%
Symptom
11%
Systematic Review
11%
Patient with Post-Traumatic Stress Disorder
11%
Headache and Facial Pain
11%
Observational Study
11%
4 Iodo 2,5 Dimethoxyamphetamine
11%
Functional Neurological Disorder
11%
Functional Magnetic Resonance Imaging
11%
Disorientation
11%
Psychiatric Assessment
11%
Psychiatry
11%
Electronic Patient Record
11%
Negative Syndrome
11%
Positive Syndrome
11%
Principal Component Analysis
11%
Patient Health Questionnaire 9
11%
Fibromyalgia
11%
Inflammatory Bowel Disease
11%
Headache
9%
Posttraumatic Stress Disorder
6%
Visual Analog Scale
5%
McGill Pain Questionnaire
5%
MIDAS (Migraine)
5%
Anxiety Disorder
5%
Clinical Trial
5%
Pharmacology, Toxicology and Pharmaceutical Science
Medical Cannabis
100%
Cannabis
82%
Adverse Event
56%
Generalized Anxiety Disorder
33%
Psilocybin
25%
Psychotomimetic
18%
Combination Therapy
13%
Chronic Pain
13%
Depressive Disorder
12%
Treatment Resistant Depression
11%
Neurologic Disease
11%
Headache and Facial Pain
11%
Fibromyalgia
11%
Inflammatory Bowel Disease
11%
Posttraumatic Stress Disorder
11%
Observational Study
11%
Headache
9%
Anxiety Disorder
8%
Migraine
8%
Clinical Trial
5%
Neuroscience
Cannabis
66%
Psychotomimetic
29%
Depressive Disorder
28%
Psilocybin
20%
Sleep Quality
13%
Meta-Analysis
12%
Generalized Anxiety Disorder
11%
Mental Disorder
11%
Body Mass Index
11%
Functional Magnetic Resonance Imaging
11%
Disorientation
11%
Negative Syndrome
11%
Functional Neurological Disorder
11%
Headache
11%
Psychiatric Assessment
11%
DNA Template
11%
Fibromyalgia
11%
Positive Syndrome
11%
Psychiatry
11%
Single-Nucleotide Polymorphism
5%
